who .png

World Health Organization (WHO) Recommendation to Reschedule Cannabis

The forty-first meeting of the WHO Expert Committee on Drug Dependence (ECDD) convened from 12 to 16 November 2018 at WHO headquarters in Geneva.  Following recommendations made by the fortieth ECDD in June 2018 regarding the pre-review of cannabis and cannabis-related substances, the forty-first ECDD carried out critical reviews of these substances to determine the most relevant level of international control for cannabis and cannabis-related substances and whether the World Health Organization should recommend changes in the level of control.   

The review of the cannabis and cannabis-related substances was carried out in relation to Resolution 52/5 of the Commission on Narcotic Drugs.  With reference to Article 3 of the Single Convention as amended by the 1972 Protocol, and Article 2 of the Convention on Psychotropic Substances, the forty-first meeting of the ECDD is pleased to submit recommendations regarding the review of cannabis and cannabis-related substances.  

WHO recommends to Reschedule or Delete from the Single Convention on Narcotic Drugs (1961) and the Convention on Psychotropic Substances (1971) 

1. cannabis 

2. cannabis resin

3. delta-9-tetrahydrocannabinol

4. delta-9-tetrahydrocannabinol isomers

5. extracts

6. tinctures

7. cannabidiol preparations

World Health Organization

20, Avenue Appia - CH - 1211 Geneva 27 - Switzerland